Showing results (291-300 of 602) with videos related to
Sort By:
Pageof 61
The Journal of Clinical Investigation|July 1, 2026
Targeted degradation of MDM2 overcomes feedback regulation of p53 signaling in Merkel cell carcinoma modelsVarsha Ananthapadmanabhan, Simone Bruno, Leonard Vonk, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 25, 2017
Impact of Post-Transplant Response and Minimal Residual Disease on Survival in Myeloma with High-Risk CytogeneticsRajshekhar Chakraborty, Eli Muchtar, Shaji K Kumar, et al.Cancer Discovery|May 4, 2021
Impact of HER2 Heterogeneity on Treatment Response of Early-Stage HER2-Positive Breast Cancer: Phase II Neoadjuvant Clinical Trial of T-DM1 Combined with PertuzumabOtto Metzger Filho, Giuseppe Viale, Shayna Stein, et al.Science Translational Medicine|July 8, 2011
Optimization of dosing for EGFR-mutant non-small cell lung cancer with evolutionary cancer modelingJuliann Chmielecki, Jasmine Foo, Geoffrey R Oxnard, et al.Cell Reports|January 28, 2014
Inference of tumor evolution during chemotherapy by computational modeling and in situ analysis of genetic and phenotypic cellular diversityVanessa Almendro, Yu-Kang Cheng, Amanda Randles, et al.Blood|June 16, 2011
Efficacy of retreatment with immunomodulatory drugs (IMiDs) in patients receiving IMiDs for initial therapy of newly diagnosed multiple myelomaSumit Madan, Martha Q Lacy, Angela Dispenzieri, et al.Haematologica|December 7, 2005
Combination therapy with thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma not undergoing upfront autologous stem cell transplantation: a phase II trialDavid Dingli, S Vincent Rajkumar, Grzegorz S Nowakowski, et al.Haematologica|May 6, 2017
Serial measurements of circulating plasma cells before and after induction therapy have an independent prognostic impact in patients with multiple myeloma undergoing upfront autologous transplantationRajshekhar Chakraborty, Eli Muchtar, Shaji K Kumar, et al.Leukemia & Lymphoma|October 29, 2020
Retroperitoneal involvement with light chain amyloidosis- case series and literature reviewIuliana Vaxman, Alissa Visram, Oren Pasvolsky, et al.Transplantation and Cellular Therapy|April 10, 2021
Prognostic Implications of Rising Serum Monoclonal Protein and Free Light Chains after Autologous Stem Cell Transplantation in Patients with Multiple MyelomaHarsh Parmar, Abdullah S Al Saleh, Alissa Visram, et al.Pageof 61